2Q-2022 and 1H-2022 Earnings Overview

CBAK Energy Technology, Inc. (Nasdaq: CBAT), a leading China-based lithium-ion battery manufacturer and electric energy solution provider released its second quarter and the first-half of 2022 earnings ended June 30.

Following the momentous first quarter of 2022, CBAT had once again achieved another significant milestone with sustained sales momentum in both battery products and battery materials in the second quarter of 2022. 

Specifically, net revenues from the battery business alone grew by approximately 337% year-over-year in Q2, while the overall revenues grew by 857% and 792% year-over-year, reaching $56.4 million and $136.5 million in the second quarter and the first half of 2022, respectively.

With great resources pouring into the new energy industry by the government on the back of robust market demand, CBAT management has been proactively expanding the Company's new energy batteries production capacity and R&D investment, which had transpired to remarkable sales performance so far this year.

Specifically on production capacity expansion, in addition to the Dalian production center currently with an annual capacity of 1GWh, there are also two planned phases for the Company's new Nanjing manufacturing center.  Phase I was only put in production at an initial capacity of 0.7GWh in late 2021, grown to 1GWh currently, and is expected to double that to 2GWh around the end of 2022 or early 2023.

However, such level of capacity remains far below the industry's elevating demand.  The initial Phase II operation is expected to start in late 2023, with a target to deliver 6GWh per year until an annual capacity of 18GWh is reached. 

In terms of end-product applications, the Nanjing plant will mainly focus on producing large cylindrical batteries catered for the EV/LEV customers, while Dalian facilities will continue to focus on the Company's matured models (e.g. 26650/26700 batteries), which are catered to the energy storage industry.

As expected, CBAT received additional orders in the second quarter, and more orders of larger size is believed to start in the 3rd quarter of 2022. 

Following the sample delivery of battery packs worth of $208,000 to Azapa and Daihatsu, the order backlog stood at $55.35 million as of Aug. 5, 2022. The Company is now producing more samples of battery systems, and anticipates to receive an order of 5,000 to 10,000 units of battery pack from Daihatsu next year.

Although the price hikes in battery raw materials remained a setback to the Company's battery production margins, CBAT management has been taking actions to mitigate its impact, such as signing long-term supply agreements with major suppliers to secure major materials supplies, expanding into the upstream raw material business and use battery material price inflation to offset the decrease in gross margins of battery plants, and renegotiating prices with downstream customers to successfully raise product prices for the Company's key customers.

Meanwhile, CBAK has also continued making investments into sales & marketing and R&D to grow orders and innovation, and into new facilities to extend production capacity catered to growing orders and economy of scale.

Notably, despite that gross margins remained under pressure, the Company's operating expenses as percentage of revenues were lowered to 9.6% and 8.8% in Q2 and the first half of 2022, a significant drop from 64.9% and 37.2% in the same period of 2021, respectively.

CBAT management's decision to acquire battery material supplier Hitrans has proved to be a strategic move and a successful investment. Nevertheless, the management team remains vigilant in the search of other investment opportunities and/or valuable acquisition targets along the line of battery production supply chain for vertical integration.

Following the announcement of the strategic corporation framework with Jemmell, a LEV manufacturing unit of JP Group which is one of China's biggest LEV manufacturers in July, several samples provided by CBAT are currently under testing. Once the sample testing passes the requirement, the Company anticipates to start receiving numerous orders from Jemmell and JP Group down the road. Meanwhile, the management is also approaching more LEV and EV manufacturers.

Together, these efforts should lead to more valuable new orders, setting stage for strong EV/LEV sales performance in the second half of 2022.

Larger cylindrical batteries such as Model 42140 are much better suited for EV/LEV market applications.  While as the testing on this new model had proved successful in Q2, the Company is now gearing up to establish its production lines to support strong market demand.

Though still at its early stage, the market for sodium-ion batteries is expected worth of billions of dollars. CBAT's prototype was already out and has passed the test, prompting the management to see the potential for its mass production in the second half of this year.

Net revenues were $56.4 million, representing a year-over-year increase of 857%, mainly driven by strong sales of high-power lithium batteries and materials for use in manufacturing lithium battery.

Among which, net revenues from batteries used in LEV grew by 597% YoY in the quarter.

Q2-2022 gross profit margin was 8%, a decrease of 11% from 2021. down from 19.5% in 1Q-2021, primarily due to the increase in raw material prices, which are expected to abate when new capacity is being added by the overall industry.

Total operating expenses increased 112% YoY, primarily due to growing headcount, the acquisition of battery material business Hitran, and a growing number of employees for the new facility in Nanjing. Among which, R&D expense in particular increased 267% YoY, coupled with 103% YoY increase in Sales & Marketing expenses.  Despite the increases, operating expenses as percentage of revenues was limited to 9.6% in the quarter, down significantly from 64.9% from a year ago.

Net income attributable to CBAT shareholders was $1.3 million, compared to $32.3 million in Q2-2021, mainly attributed to higher warrants liability. Change in CBAT warrant's fair value was $3.8 million in Q2-2022, compared to $34.2 million in the same period of 2021. Basic and fully-diluted income per share were both $0.01 in the quarter, compared to a net loss per share of $0.37 in Q2-2021. 

Cash and cash equivalents were $4.38 million as of June 30, 2022, compared to $7.36 million as of December 31, 2021.

Stone Street Group LLC ("Stone Street") publishes research reports on publicly-traded companies. Stone Street has been retained by the Company discussed in this report (the "Company") to provide ongoing digital investor relations services, including the creation and dissemination of this report. All research published by Stone Street is based on public information, or on information from the Company that the Company is required to promptly make public.

Stone Street is not a broker-dealer or a "covered person" under SEC Regulation AC, and does not distribute its research through a registered broker-dealer or any associated person of a registered broker-dealer. Accordingly, Stone Street is exempt from the provisions of Regulation AC. Nevertheless, Stone Street makes the following voluntary disclosures and disclaimers in connection with its research reports:

NO GUARANTEE:  This research report is not a substitute for the exercise of an investor's independent due diligence and independent investment determinations. Information contained herein is based on sources we believe to be reliable but we do not guarantee their accuracy. It should be presumed that the analyst who authored this report has had discussions with the Company to endeavor to ensure factual accuracy prior to publication, however, no independent due diligence or verification has been undertaken by the analyst.  No endorsements are made in respect of information provided or published by the subject Company and relied upon by the analyst for purposes of this research report. Recipients of this report should consider this report as only one factor in making any investment decision. This report is for information purposes only and is not intended as an offer to sell or a solicitation to buy securities.  Any and all information provided by the Company which has been publicly disclosed as "forward looking information" remains subject to all uncertainties in such regard and Stone Street makes no assurances or guaranties of actual outcomes. 

NO CONFLICTS OF INTEREST:  Stone Street does NOT own securities of the issuers described herein, and Stone Street does not make a market in any securities. Stone Street does not engage in, or receive compensation from, any investment banking or corporate finance-related activities with the Company discussed in the report. Stone Street's contracts with issuers protect Stone Street's full editorial control of all research, timing of release of reports, and release from liability for negative reports.

ANALYST INDEPENDENCE:  Each Stone Street analyst has full discretion on the analysis and revenue targets contained in the report, based on his or her own due diligence. Analysts are paid in part based on overall profitability of Stone Street. No part of analyst compensation was, or will be, directly or indirectly, related to the specific recommendations or views expressed in any report or article. Stone Street policy does not allow an analyst or a member of their household (i) to own, trade, or have any beneficial interest in any securities of any Company that analyst covers, or (ii) serve as an officer or director of a covered Company.

RISK FACTORS:  Earnings targets and opinions concerning the composition of market sectors included in this report reflect analyst judgments as of this date and are subject to change without notice. A risk to our earnings targets is that the analyst's estimates or forecasts may not be met. This report contains forward-looking statements, which involve risks and uncertainties. Actual results may differ significantly from such forward-looking statements. Factors that may cause such differences include, but are not limited to, those discussed in the "Risk Factors" section in the issuer's SEC filings available in electronic format through SEC Edgar filings at www.sec.gov.

COMPENSATION:  Stone Street received a flat fee from or on behalf of the Company for the creation and dissemination of the report. Stone Street has not received investment banking income from the Company in the past 12 months, and does not expect to receive investment banking income from the Company in the next 12 months.

ANALYST CERTIFICATION:  The research analyst certifies that this report accurately reflects his/her personal views about the Company's securities that none of the research analyst's compensation was, is or will be, directly or indirectly, related to the analyst's specific recommendations or views contained in this research report.